07:00 , Jun 17, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Shock Allergin-1 (C17orf60) In vitro and mouse studies suggest that agonizing allergin-1 could help decrease proinflammatory degranulation of mast cells to treat anaphylactic shock....